Literature DB >> 17401748

Immunoglobulin-responsive dysautonomia in Sjögren's syndrome.

Yusuf A Rajabally, Hanny Seow, Richard J Abbott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17401748     DOI： 10.1007/s00415-006-0378-6

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Five-year efficacy of intravenous gammaglobulin to treat dysautonomia in Sjögren's syndrome.

Authors:  J L Dupond; H Gil; B de Wazieres
Journal:  Am J Med       Date:  1999-01       Impact factor: 4.965

3.  Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjögren's syndrome.

Authors:  J A Molina; J Benito-León; F Bermejo; F J Jiménez-Jiménez; J Oliván
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

4.  Autonomic neuropathy associated with sicca complex.

Authors:  R A Wright; I A Grant; P A Low
Journal:  J Auton Nerv Syst       Date:  1999-01-15

5.  The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.

Authors:  Keiko Mori; Masahiro Iijima; Haruki Koike; Naoki Hattori; Fumiaki Tanaka; Hirohisa Watanabe; Masahisa Katsuno; Asako Fujita; Ikuko Aiba; Akihiko Ogata; Toyokazu Saito; Kunihiko Asakura; Mari Yoshida; Masaaki Hirayama; Gen Sobue
Journal:  Brain       Date:  2005-07-27       Impact factor: 13.501

6.  Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sjögren's syndrome.

Authors:  M Lee; J A Rutka; A R Slomovic; J McComb; D J Bailey; A A Bookman
Journal:  J Rheumatol       Date:  1998-02       Impact factor: 4.666

7.  Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin.

Authors:  Y Takahashi; T Takata; M Hoshino; M Sakurai; I Kanazawa
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910
  7 in total
  1 in total

Review 1.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.